{"entity":{"type":"insider","cik":"0001527510","url":"/insider/0001527510","json_url":"/insider/0001527510.json","name":"Longitude Venture Partners II, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":8,"first":"2015-08-11","last":"2026-02-06","span_basis":"filed_date"},"name_variants":[{"name":"Longitude Venture Partners II, L.P.","source":"filing","n_filings":8,"first_seen":"2015-08-11","last_seen":"2026-02-06"}],"transactions":[{"id":6036226,"accession":"0001193125-26-041248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-041248","line_url":"/filing/0001193125-26-041248#line-1","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"RAPID MICRO BIOSYSTEMS, INC.","issuer_ticker":"RPID","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"ENRIGHT PATRICK G; Longitude Capital Partners II, LLC; Longitude Prime Fund, L.P.; Longitude Prime Partners, LLC; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49000.0,"shares_display":"49,000","price_per_share":3.8794,"price_display":"3.88","price_state":"stated","total_value":190090.6,"total_display":"190,090.60","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-04","filed_date":"2026-02-06","scope":"insider"},{"id":6036159,"accession":"0001193125-26-036387","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-26-036387","line_url":"/filing/0001193125-26-036387#line-5","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"RAPID MICRO BIOSYSTEMS, INC.","issuer_ticker":"RPID","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"ENRIGHT PATRICK G; Longitude Capital Partners II, LLC; Longitude Prime Partners, LLC; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27500.0,"shares_display":"27,500","price_per_share":4.2415,"price_display":"4.24","price_state":"stated","total_value":116641.25,"total_display":"116,641.25","shares_owned_after":49000.0,"shares_owned_after_display":"49,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-03","scope":"insider"},{"id":6036156,"accession":"0001193125-26-036387","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-036387","line_url":"/filing/0001193125-26-036387#line-4","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"RAPID MICRO BIOSYSTEMS, INC.","issuer_ticker":"RPID","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"ENRIGHT PATRICK G; Longitude Capital Partners II, LLC; Longitude Prime Partners, LLC; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27500.0,"shares_display":"27,500","price_per_share":4.246,"price_display":"4.25","price_state":"stated","total_value":116765.0,"total_display":"116,765.00","shares_owned_after":76500.0,"shares_owned_after_display":"76,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-03","scope":"insider"},{"id":6036153,"accession":"0001193125-26-036387","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-036387","line_url":"/filing/0001193125-26-036387#line-3","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"RAPID MICRO BIOSYSTEMS, INC.","issuer_ticker":"RPID","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"ENRIGHT PATRICK G; Longitude Capital Partners II, LLC; Longitude Prime Partners, LLC; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46000.0,"shares_display":"46,000","price_per_share":4.5435,"price_display":"4.54","price_state":"stated","total_value":209001.0,"total_display":"209,001.00","shares_owned_after":104000.0,"shares_owned_after_display":"104,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-02-03","scope":"insider"},{"id":6036146,"accession":"0001193125-26-036387","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-036387","line_url":"/filing/0001193125-26-036387#line-1","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"RAPID MICRO BIOSYSTEMS, INC.","issuer_ticker":"RPID","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"ENRIGHT PATRICK G; Longitude Capital Partners II, LLC; Longitude Prime Partners, LLC; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7739.0,"shares_display":"7,739","price_per_share":4.064,"price_display":"4.06","price_state":"stated","total_value":31451.296,"total_display":"31,451.30","shares_owned_after":4029245.0,"shares_owned_after_display":"4,029,245","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-23","filed_date":"2026-02-03","scope":"insider"},{"id":4305930,"accession":"0000899243-21-029105","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-029105","line_url":"/filing/0000899243-21-029105#line-2","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"RAPID MICRO BIOSYSTEMS, INC.","issuer_ticker":"RPID","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"Longitude Capital Partners II, LLC; Longitude Prime Partners, LLC; ENRIGHT PATRICK G; Longitude Prime Fund, L.P.; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","shares_owned_after":150000.0,"shares_owned_after_display":"150,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-19","filed_date":"2021-07-20","scope":"insider"},{"id":6251178,"accession":"0001140361-18-031069","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-031069","line_url":"/filing/0001140361-18-031069#line-3","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"ENRIGHT PATRICK G; Longitude Capital Partners II, LLC; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":131579.0,"shares_display":"131,579","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":2500001.0,"total_display":"2,500,001.00","shares_owned_after":3019734.0,"shares_owned_after_display":"3,019,734","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-02","scope":"insider"},{"id":6649041,"accession":"0001104659-18-042312","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-18-042312","line_url":"/filing/0001104659-18-042312#line-4","is_derivative":false,"issuer_cik":"0001431159","issuer_name":"Aptinyx Inc.","issuer_ticker":"APTX","issuer_name_source":null,"issuer_url":"/issuer/0001431159","owner_cik":null,"owner_name":"Tammenoms Bakker Juliet; Longitude Venture Partners II, L.P.; Longitude Capital Partners II, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":2400000.0,"total_display":"2,400,000.00","shares_owned_after":3190079.0,"shares_owned_after_display":"3,190,079","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-25","filed_date":"2018-06-26","scope":"insider"},{"id":4324397,"accession":"0001209191-17-046462","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-046462","line_url":"/filing/0001209191-17-046462#line-2","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"ENRIGHT PATRICK G; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet; Longitude Capital Partners II, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":215000.0,"shares_display":"215,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3225000.0,"total_display":"3,225,000.00","shares_owned_after":2270946.0,"shares_owned_after_display":"2,270,946","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-07-25","filed_date":"2017-07-27","scope":"insider"},{"id":2782957,"accession":"0001209191-16-111235","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-111235","line_url":"/filing/0001209191-16-111235#line-2","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"Tammenoms Bakker Juliet; Longitude Capital Partners II, LLC; Longitude Venture Partners II, L.P.; ENRIGHT PATRICK G","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45440.0,"shares_display":"45,440","price_per_share":14.1465,"price_display":"14.15","price_state":"stated","total_value":642816.96,"total_display":"642,816.96","shares_owned_after":7513134.0,"shares_owned_after_display":"7,513,134","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-03-29","filed_date":"2016-03-31","scope":"insider"},{"id":2782953,"accession":"0001209191-16-111235","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-111235","line_url":"/filing/0001209191-16-111235#line-1","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"Tammenoms Bakker Juliet; Longitude Capital Partners II, LLC; Longitude Venture Partners II, L.P.; ENRIGHT PATRICK G","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33064.0,"shares_display":"33,064","price_per_share":13.4986,"price_display":"13.50","price_state":"stated","total_value":446317.7104,"total_display":"446,317.71","shares_owned_after":7467694.0,"shares_owned_after_display":"7,467,694","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-03-29","filed_date":"2016-03-31","scope":"insider"},{"id":8737906,"accession":"0000899243-15-002783","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-15-002783","line_url":"/filing/0000899243-15-002783#line-3","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"Longitude Capital Partners II, LLC; ENRIGHT PATRICK G; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","shares_owned_after":7434630.0,"shares_owned_after_display":"7,434,630","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-11","filed_date":"2015-08-11","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001380106","name":"RAPID MICRO BIOSYSTEMS, INC.","url":"/issuer/0001380106","role":"Ten percent owner","n_filings":3,"first_seen":"2021-07-20","last_seen":"2026-02-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001595585","name":"Tricida, Inc.","url":"/issuer/0001595585","role":"Ten percent owner","n_filings":1,"first_seen":"2018-07-02","last_seen":"2018-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001674365","name":"Aptinyx Inc.","url":"/issuer/0001674365","role":"Ten percent owner","n_filings":1,"first_seen":"2018-06-26","last_seen":"2018-06-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001479419","name":"Kala Pharmaceuticals, Inc.","url":"/issuer/0001479419","role":"Ten percent owner","n_filings":1,"first_seen":"2017-07-27","last_seen":"2017-07-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001631650","name":"Aimmune Therapeutics, Inc.","url":"/issuer/0001631650","role":"Ten percent owner","n_filings":2,"first_seen":"2015-08-11","last_seen":"2016-03-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001527510","retrieved_at":"2026-08-21T01:33:01+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}